Definitive Healthcare <DH.O>: Morgan Stanley cuts target price to $1.50 from $2.50
DH•Related News
Alight adds eMed to partner network to expand employer access to GLP-1 therapies
ALIT•
Maase completes RMB 1.65 million AI computing services contract, receives full payment
MAAS•
Adamas Trust Increases Quarterly Common Stock Dividend By 11.1% To $0.30 Per Share
ADAM•
Nasdaq Trade Halt Continues <UCFI.O> Reason Not Available at 09:00 AM
UCFI•
Novo Nordisk's Awiqli®, The First Once-Weekly Basal Insulin For Adults With Type 2 Diabetes, Now Available In The US
NVO•